AOSpine outcome instruments
Disease-specific outcome tools developed and validated by AOSpine
SOSGOQ2.0 for spine oncology patients
AOSpine Knowledge Forum (KF) Tumor recently validated the first spine oncology-specific patient-reported outcome (PRO) tool, the SOSGOQ2.0.
The PRO allows you to define whether your patients are improving and will serve to improve their quality of life.
Use the SOSGOQ2.0 in combination with a generic instrument.
The study was published in Cancer, April 15, 2018 Vol. 124(8).
The SOSGOQ2.0 research has been awarded:
- AOSpine Europe's Young Researcher Award, first place, 2018
- Best Paper Award, 30th European Musculo-Skeletal Oncology Society meeting (EMSOS), 2017
“Importantly, with the SOSGOQ2.0, we could see differences between patients within the population—seriously disabled patients have lower scores compared to those who are doing better—which is what you want.”
Anne Versteeg, lead author